Pre-IND Discussion with U.S. FDA Helps BetterLife Set Up AP-003 Clinical Trials in Australia
10. November 2020 07:30 ET
|
BetterLife Pharma
VANCOUVER, Nov. 10, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company focused on development and...
BetterLife Pharma Signs eTMF Partner to Help Accelerate AP-003 Clinical Trial Operations
04. November 2020 08:00 ET
|
BetterLife Pharma
VANCOUVER, Nov. 04, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company that is beginning clinical...
BetterLife Provides Important Update on its Australian Clinical Study Design
28. Oktober 2020 08:00 ET
|
BetterLife Pharma
Vancouver, Oct. 28, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company preparing human clinical trials of AP-003, its interferon alpha 2b...
UPDATE: BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Synairgen PLC’s Interferon Beta
28. Oktober 2020 05:00 ET
|
BetterLife Pharma
NEW YORK CITY, Oct. 28, 2020 (GLOBE NEWSWIRE) -- UPDATE: BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Synairgen PLC’s Interferon Beta The Chief...
BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Other Treatements
27. Oktober 2020 07:30 ET
|
BetterLife Pharma
New York City, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company currently preparing for clinical...
BETTERLIFE PHARMA ANNOUNCES UP TO $5.0 MILLION PRIVATE PLACEMENT OFFERING OF SPECIAL WARRANTS
19. Oktober 2020 08:00 ET
|
BetterLife Pharma
VANCOUVER, Oct. 19, 2020 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART,...
BetterLife Names CRO for COVID-19 Clinical Trial in Australia
15. Oktober 2020 08:00 ET
|
BetterLife Pharma
VANCOUVER, Oct. 15, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, is pleased to announce that it...
BetterLife Announces VirTrial as Clinical Trial Patient Monitoring Partner
08. Oktober 2020 08:00 ET
|
BetterLife Pharma
VANCOUVER, Oct. 08, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, is pleased to announce that it...
BetterLife Receives FINRA Approval and Resumes Trading on the OTC Markets
30. September 2020 07:30 ET
|
BetterLife Pharma
VANCOUVER, Sept. 30, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, is pleased to announce that,...
BetterLife Provides Update on OTC Trading Activity
23. September 2020 07:30 ET
|
BetterLife Pharma
VANCOUVER, Sept. 23, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, today announced that it has...